Testosterone Therapy May Help Diabetic Men
Sexual Medicine Conferences Held This Summer
Men with type 2 diabetes may benefit from testosterone replacement therapy using testosterone undecanoate (TU), British researchers have found.
Their study involved 199 diabetic men in the United Kingdom. After confirming low testosterone levels, the researchers randomly assigned the men to receive 30 weeks of treatment with either TU or a placebo.
After 30 weeks, 106 men decided to continue with the second phase of the study, an open-label segment.
Outcomes were measured with the International Index of Erectile Function (IIEF), the Aging Male Symptom assessment (AMS), the Hospital Anxiety and Depression Scale (HADS), and the Global Efficacy Question (GEQ).
After 30 weeks, 46% of the men on testosterone therapy said they felt that their health had improved because of treatment. For the placebo group, this rate was 17%. However, after the second portion of the study, 70% of all the men thought their health had improved.
Men taking testosterone saw improvements in erectile function, intercourse satisfaction, desire, overall satisfaction, and orgasm.
Obese men and those with depression did not see as much benefit.
The study was published online in April in The Journal of Sexual Medicine. Click here to learn more.
Thinking about attending a sexual medicine conference this summer? There are several to choose from, including the following:
14th Biennial Meeting of the Asia-Pacific Society for Sexual Medicine (APSSM)
May 31, 2013 - Jun 3, 2013
International Symposium on Prostate, Androgens And Men’s Sexual Health
Jun 20, 2013 - Jun 23, 2013
XII Latin American Society of Sexual Medicine Congress (SLAMS)
Aug 28, 2013 - Aug 31, 2013
33rd Congress of the Société Internationale D’Urologie (SIU)
Sep 8, 2013 - Sep 12, 2013
Vancouver Convention Centre, Canada
A complete list of upcoming events from now through October 2014 can be found here.